PMC:7264932 / 3442-3724
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 130 | 95-103 | Species | denotes | patients | Tax:9606 |
| 131 | 132-146 | Chemical | denotes | amphotericin-B | MESH:D000666 |
| 132 | 223-235 | Chemical | denotes | voriconazole | MESH:D065819 |
| 133 | 240-253 | Chemical | denotes | isavuconazole | MESH:C508735 |
| 134 | 168-186 | Disease | denotes | multiorgan failure | MESH:D009102 |
| 135 | 197-212 | Disease | denotes | hepatic failure | MESH:D017093 |
LitCovid-PD-HP
| Id | Subject | Object | Predicate | Lexical cue | hp_id |
|---|---|---|---|---|---|
| T30 | 76-79 | Phenotype | denotes | IPA | http://purl.obolibrary.org/obo/HP_0020103 |
| T31 | 197-212 | Phenotype | denotes | hepatic failure | http://purl.obolibrary.org/obo/HP_0001399 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T40 | 168-186 | Disease | denotes | multiorgan failure | http://purl.obolibrary.org/obo/MONDO_0043726 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T21 | 145-146 | http://purl.obolibrary.org/obo/CLO_0001021 | denotes | B |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T37 | 21-42 | Chemical | denotes | antifungal medication | http://purl.obolibrary.org/obo/CHEBI_86327 |
| T38 | 21-31 | Chemical | denotes | antifungal | http://purl.obolibrary.org/obo/CHEBI_35718 |
| T39 | 76-79 | Chemical | denotes | IPA | http://purl.obolibrary.org/obo/CHEBI_17824|http://purl.obolibrary.org/obo/CHEBI_30802 |
| T41 | 223-235 | Chemical | denotes | voriconazole | http://purl.obolibrary.org/obo/CHEBI_10023 |
| T42 | 240-253 | Chemical | denotes | isavuconazole | http://purl.obolibrary.org/obo/CHEBI_85979 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T33 | 0-90 | Sentence | denotes | Early and sufficient antifungal medication is the cornerstone for effective IPA treatment. |
| T34 | 91-282 | Sentence | denotes | Our patients were treated with liposomal amphotericin-B (3 mg/kg) because of multiorgan failure including hepatic failure; however, voriconazole and isavuconazole are sufficient alternatives. |